fate stock price target

FATE were skyrocketing 473 higher as of 1143 am. The Score for FATE is 48 which is 4 below its historic median score of 50 and infers higher risk than normal.

Insider Selling Fate Therapeutics Inc Nasdaq Fate Director Sells 841 Shares Of Stock Marketbeat

Ad Our Strong Buys Double the SP.

. 13 2022 at 709 am. Following the transaction the insider now owns 127123 shares of the companys stock valued at. Get a real-time Fate Therapeutics Inc.

49 rows Close price at the end of the last trading day Monday 13th Jun 2022. The Fate Therapeutics stock price gained 053 on the last trading day Wednesday 29th Jun 2022 rising from 2475 to 2488During the day the stock fluctuated 540 from a day low at 2399 to a day high of 2529The price has risen in 7 of the last 10 days and is up by 3355 over the past 2 weeks. Based On Fundamental Analysis.

According to the issued ratings of 11 analysts in the last year the consensus rating for Fate Therapeutics stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for FATE. Analyst Price Target on FATE. Common Stock FATE at.

In-depth view of key statistics and finances for FATE THERAPEUTICS INC. Come read breaking news on stock and markets. In comparison to the median Healthcare stock FATEs pricesales ratio is 11793 higher now standing at 1452.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Stock Price Target FATE. FATE is currently trading in the 40-50 percentile range relative to its historical Stock Score levels.

Analyst ratings historical stock prices earnings estimates actuals. Volume fell on the last day by -297 thousand shares. Whats Happening With Fate Therapeutics Inc Stock Today.

FATE on MSN Money. This price move could indicate a change in the trend and may be a buy signal for investors. FATE stock forecast and price target.

NASDAQFATE - Get Rating insider Mark Plavsic sold 3719 shares of the companys stock in a transaction that occurred on Tuesday July 5th. Over the past 96 months FATEs priceearnings ratio has gone down 256. ET by Tomi Kilgore Fate Therapeutics upgraded to outperform from neutral at.

Based on this data the odds of success are 90. The average price target represents a 16280 change from the last price of 2680. This suggests a possible upside of 1762 from the stocks current price.

FATE updated stock price target summary. Find the latest Fate Therapeutics Inc. View analysts price targets for Fate Therapeutics or view top-rated stocks among Wall Street analysts.

The stock was sold at an average price of 2461 for a total transaction of 9152459. The average price target is 000 with a high estimate. The average Fate Therapeutics stock forecast represents a 12228 increase from the last price of 38689998626709.

Fate Therapeutics Stock Forecast 06-21-2022. FATE stock price quote with breaking news financials statistics charts and more. The current Fate Therapeutics Inc FATE share price is 2310.

Fate Therapeutics Inc FATE stock is trading at 6135 as of 1146 AM on Thursday Dec 30 a rise of 213 or 359 from the previous closing price of 5922. The stock has traded between 5852 and 6228 so far today. What happenedShares of Fate Therapeutics NASDAQ.

Stock Price Forecast The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 8200 with a high estimate of 13500 and a low estimate of 2800. AlTorress Aug 7 2020. FATE stock quote history news and other vital information to help you with your stock trading and investing.

The average twelve-month price prediction for Fate Therapeutics is 8036 with a high price target of 11600 and a low price target of 2800. The average price target is 7043 with a high forecast of 11500 and a low forecast of 2800. So far 166777 shares have traded compared.

Fate Therapeutics stock price target cut to 75 from 125 at Truist Apr. Their FATE stock forecasts range from 2800 to 11600. The current analyst and expert consensus on Fate Therapeutics is Buy with 4 hold recommendations.

8313 2355 Earnings Date. The huge jump came after the biotech announced positive interim data from an. Volume today is light.

FATE analyst stock forecast price target and recommendation trends with in. Ad Monitoring Breaking Stock and Market News From Around the World. Forecast target price for 06-21-2022.

Find the latest analyst research for Fate Therapeutics Inc. Get a real-time Fate Therapeutics Inc. FATE 3342 price moved above its 50-day MA on August 06 2020.

16280 Upside Based on 9 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. Positive dynamics for Fate Therapeutics shares. A high-level overview of Fate Therapeutics Inc.

And for a list of of all stocks sorted by upside potential based on analyst. Ad These 5 fascinating stocks are the most important investments for the next 90 days. One of the most common ways Fate Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial.

On average they predict Fate Therapeutics share price to reach 8036 in the next year. Tickeron AIdvisor found 46 similar cases and 46 were successful. Tiny company is a sneaky EV play that no ones talking about but should be.

The current projected Fate Therapeutics target price consensus is 1072 with 15 analyst opinions. FATE stock price quote with breaking news financials statistics charts and more. Find the latest Fate Therapeutics Inc.

For more insight on analysts targets of FATE see our FATE price target page. The 3 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of 860 with a high forecast of 1220 and a low forecast of 620. 7 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 7643 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 2800.

Fate Therapeutics Inc.

Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S